Neoplast SPRL
Neoplast reported total assets of €4.59m at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Mar 2026).
The score of Neoplast shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets +46 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Neoplast's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Mar 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 13 May 2024
- Year ended 31 Dec 2022filed on 17 May 2023
- Year ended 31 Dec 2021filed on 25 Apr 2022
Neoplast's financial analysis
- Solvency98.0%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Neoplast
Neoplast's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0821.712.437
- VAT number
- BE0821712437
- Peppol
- Registered · 0208:0821712437 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 23 Dec 2009
- Registered office
- 1860 Meise
- Latest accounts
- 2025 · filed on 27 Mar 2026
- Activity
- Medical specialists activities (NACE 86220)
Neoplast (SPRL) has been based in Meise since 2009, active in: medical specialists activities. For 2025, it reports a net profit of 422,047 € and equity of €4.50m; its revenue is not published. Its solvency stands at 98.0%, above the median of its sector (72.2%).
Companies similar to Neoplast
Companies in the same business, of comparable size and area, outside its group.
- DR. Oris ELS Medical specialists activities Hasselt · balance sheet €4.75m
- DR. LUC VAN Zandweghe Medical specialists activities Lebbeke · balance sheet €5.82m
- DAG-med Medical specialists activities Estinnes · balance sheet €2.77m
- Kingyn Medical specialists activities Brasschaat · balance sheet €4.21m
- Movendi Medical specialists activities Hasselt · balance sheet €3.57m
- DR. H. Daniels Geriatrie Medical specialists activities Hasselt · balance sheet €3.56m
- Medisch Kabinet Maes Medical specialists activities Hove · balance sheet €3.53m
- DR. DE Meester & DR. Serbruyns Medical specialists activities Sint-Niklaas · balance sheet €6.06m
Frequently asked questions about Neoplast
What is the revenue of Neoplast?
Neoplast files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Neoplast?
In Belgium, the VAT number is the company number prefixed with BE: BE0821712437 for Neoplast, if the company is VAT-registered. Its company number (CBE) is 0821.712.437.
Where is the registered office of Neoplast?
According to the CBE register, the registered office of Neoplast is in 1860 Meise.
What is the equity of Neoplast?
At the close of the 2025 financial year, the equity of Neoplast amounts to 4,495,689 €, a solvency of 98.0% of total assets.
Who manages Neoplast?
The register lists 1 active mandates at Neoplast. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Neoplast
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →